Chennai Pharma Firm Under ED Net in Rs 637 Crore Bank Fraud Case
- byDoctor News Daily Team
- 21 September, 2025
- 0 Comments
- 0 Mins

Chennai: The Enforcement Directorate (ED) has launched multi-state raids across Tamil Nadu, West Bengal, and Goa, targeting Chennai-based pharmaceutical company Arvind Remedies and its promoter Arvind B. Shah in connection with a Rs 637 crore bank loan fraud. The action comes as part of an ongoing money laundering investigation under the Prevention of Money Laundering Act (PMLA), following allegations that the company defrauded a consortium of banks led by Punjab National Bank (PNB). The alleged fraud dates back to October 2016, when the CBI filed an FIR against Arvind Remedies and its promoter for diverting funds through shell companies controlled by the promoters. Dummy directors, appointed through brokers, reportedly managed these companies without knowledge of their operations. Funds were rotated across these entities to inflate turnover, secure additional bank loans, and manipulate share prices for personal gain. On September 2, 2025, ED teams conducted coordinated raids at Chennai and Kanchipuram (Tamil Nadu), Kolkata (West Bengal), and selected premises in Goa. The operations aimed to seize illegal assets and collect crucial evidence regarding the fraudulent transactions, according toThe Hindu. Authorities are now analyzing seized documents and digital records to trace the flow of illicit funds and identify all individuals involved. Also Read: ED attaches properties worth Rs 85 lakh in Karnataka's medical college stipend scam
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Mumbai's GT Hospital doctor injured after ceiling...
- 20 October, 2025
Rajasthan HC Quashes Ban on New B.Pharm Colleges,...
- 20 October, 2025
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufactu...
- 20 October, 2025
CDSCO Panel Rejects Pure and Cure's Empagliflozin-...
- 20 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!